journal article·2018-06Open access

Mobile Magnetic Nanocatalysts for Bioorthogonal Targeted Cancer Therapy

Marcus Hoop, Ana Sofia Ribeiro, Daniel Rösch, Philipp Weinand, Nuno Mendes, Fajer Mushtaq, Xiang‐Zhong Chen, Yang Shen, Carlos Franco Pujante, Josep Puigmartí‐Luis, Joana Paredes, Bradley J. Nelson, Ana Paula Pêgo, Salvador Pané

Advanced Functional Materials· Volume 28· Issue 25

Abstract

Abstract The use of magnetic nanorobots to activate chemotherapeutic prodrugs represents a promising alternative to current chemotherapeutic treatments. Here, a hybrid nanowire (NW) for targeted bioorthogonally driven activation of the latent chemotherapeutic prodrug 5‐fluoro‐1‐propargyl‐uracil (Pro‐5‐FU) in in vitro and in vivo cancer models is proposed. The NWs are composed of magnetic iron (Fe) and palladium (Pd), a known bioorthogonal catalyst. In vitro tests with a cancer cell line showed no significant cytotoxic effect by the NWs. In contrast, NWs combined with Pro‐5‐FU lead to a significant reduction of cell viability, similarly to the one induced by its active chemotherapeutic counterpart 5‐fluorouracil (5‐FU). The reduction in cell viability is attributed to the catalytic activation of Pro‐5‐FU into 5‐FU. To demonstrate their targeted therapeutic abilities, magnetic fields are used to attract the FePd NWs to a predefined area within a cultured cancer cell population, causing a local Pro‐5‐FU activation, and subsequent cell death in this region. As a proof of concept, NWs are injected in cancer tumor xenografts. The intraperitoneal injection of Pro‐5‐FU significantly retards tumour growth without causing significant side effects. This work presents a novel chemotherapeutic approach combining nanorobotics and bioorthogonal activation of prodrugs as an efficient alternative to conventional chemotherapy.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Micro and Nano Robotics · Advanced biosensing and bioanalysis techniques · Nanoplatforms for cancer theranostics

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Institute of Robotics and Intelligent Systems (IRIS) ETH Zurich Tannenstrasse 3 CH‐8092 Zurich Switzerland

IPATIMUP – Institute of Molecular Pathology and Immunology of the University of Porto Rua Júlio Amaral de Carvalho, 45 4200‐135 Porto Portugal

i3S – Institute for Investigation and Innovation in Health University of Porto, Portugal Rua Alfredo Allen 208 4200‐135 Porto Portugal

Institute of Food, Nutrition and Health ETH Zurich Schmelzbergstrasse 7 CH‐8092 Zurich Switzerland

Institute of Chemical and Bioengineering ETH Zürich Vladimir Prelog Weg 1 8093 Zurich Switzerland

INEB – Instituto de Engenharia Biomédica Rua Alfredo Allen 208 4200‐135 Porto Portugal

Instituto de Ciências Biomédicas Abel Salazar (ICBAS) Universidade do Porto Rua de Jorge Viterbo Ferreira 228 4050‐313 Porto Portugal

Faculdade de Engenharia da Universidade do Porto R. Dr. Roberto Frias 4200‐465 Porto Portugal

Funding

Scientific Center for Optical and Electron Microscopy (ScopeM) of ETH

References (41)

Show source-provided references
1. 10.1038/nrc.2017.1710.1038/nrc.2017.17 ↗
2. 10.1634/theoncologist.12-12-144310.1634/theoncologist.12-12-1443 ↗
3. 10.1038/nrc152910.1038/nrc1529 ↗
4. MacDonald V. · Can. Vet. J. · 2009 · 50 · 665
5. 10.1016/j.ctrv.2014.03.00510.1016/j.ctrv.2014.03.005 ↗
6. 10.1038/nrc162910.1038/nrc1629 ↗
7. 10.1007/978-1-60761-416-6_2110.1007/978-1-60761-416-6_21 ↗
8. 10.2174/09298670878513299710.2174/092986708785132997 ↗
9. 10.1208/s12248-014-9638-z10.1208/s12248-014-9638-z ↗
10. 10.4155/tde.12.6110.4155/tde.12.61 ↗
11. 10.1038/nrd246810.1038/nrd2468 ↗
12. 10.1021/jm030381210.1021/jm0303812 ↗
13. 10.1021/ar200148z10.1021/ar200148z ↗
14. 10.1021/jm500531z10.1021/jm500531z ↗
15. 10.1016/j.chembiol.2014.09.00210.1016/j.chembiol.2014.09.002 ↗
16. 10.1002/anie.20140454710.1002/anie.201404547 ↗
17. 10.1038/nchem.228410.1038/nchem.2284 ↗
18. 10.1016/j.cbpa.2014.07.00710.1016/j.cbpa.2014.07.007 ↗
19. 10.1038/nnano.2010.23510.1038/nnano.2010.235 ↗
20. 10.1038/nchem.188710.1038/nchem.1887 ↗
21. 10.1039/C5SC00070J10.1039/C5SC00070J ↗
22. 10.3389/fchem.2014.0005610.3389/fchem.2014.00056 ↗
23. 10.1038/ncomms427710.1038/ncomms4277 ↗
24. da Silva Luz G. V. · Mater. Sci. Eng. A · 2016 · 6 · 167
25. 10.1166/jnn.2006.41310.1166/jnn.2006.413 ↗
26. 10.1038/nmat379810.1038/nmat3798 ↗
27. Reza K. H. · Int. J. Pharm. Sci. Rev. Res. · 2011 · 10 · 60
28. 10.1039/C6NR02228F10.1039/C6NR02228F ↗
29. 10.1002/adma.20160545810.1002/adma.201605458 ↗
30. 10.1002/adma.20130087510.1002/adma.201300875 ↗
31. 10.1021/acs.chemrev.5b0004710.1021/acs.chemrev.5b00047 ↗
32. 10.1126/scirobotics.aam643110.1126/scirobotics.aam6431 ↗
33. 10.1021/nn404501g10.1021/nn404501g ↗
34. 10.1002/9780470602638.ch1110.1002/9780470602638.ch11 ↗
35. 10.2166/wst.2007.01710.2166/wst.2007.017 ↗
36. 10.1038/nrc167010.1038/nrc1670 ↗
37. 10.1595/147106712X65174810.1595/147106712X651748 ↗
38. Ivanov Y. P. · Sci. Rep. · 2016 · 6 · 110.1038/s41598-016-0001-8 ↗
39. 10.1063/1.369206810.1063/1.3692068 ↗
40. 10.7150/ijbs.5.46610.7150/ijbs.5.466 ↗
41. Thomas S. A. · Cancer Cell Microenviron. · 2016 · 3 · 1